GleamWall
中文EN

HCWB HCW Biologics Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1828673 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1,487.6%
TTM net income YoY64.7%
TTM EPS YoY162.3%
Revenue 3-yr CAGR32.8%
Net income 3-yr CAGR—

Margins

Gross margin96.6%
Operating margin-104.2%
Net margin-63.4%
FCF margin—
EBITDA margin-96.1%

Returns

ROE-180.3%
ROA-16.8%
ROIC (approx.)-116.5%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets72.8%
Debt / equity0.00x
Current ratio0.07x
Interest coverage-12.39x

Cash quality & payout

Operating cash flow / net income2.71x
Accruals ratio28.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$54,232$2.57M
Cost of revenue$43,386$1.61M
Gross profit$10,846$959,403
R&D expense$5.44M$6.39M
SG&A expense$7.70M$6.82M
Operating income-$13.16M-$29.46M
Interest expense$845,051$654,284
Pretax income-$7.96M-$30.02M
Income tax$0$0
Net income-$7.96M-$30.02M
EBITDA-$12.12M-$28.27M
EPS (basic)-10.63-30.96
EPS (diluted)-10.63-30.96
Weighted avg. shares (diluted)2.10M969,825
Balance sheet
Cash & equivalents$1.95M$4.67M
Short-term investments$0$0
Receivables$32,175$582,201
Current assets$2.28M$5.70M
PP&E, net$20.88M$22.91M
Total assets$24.52M$30.24M
Current liabilities$21.06M$29.63M
Short-term debt$6.81M$6.31M
Long-term debt$0$7.38M
Total debt$6.81M$13.69M
Total liabilities$21.76M$37.01M
Shareholders' equity$2.76M-$6.77M
Net debt$4.86M$9.02M
Cash flow statement
Operating cash flow-$13.39M-$14.23M
Capital expenditure$0$261,617
Free cash flow-$13.39M-$14.49M
Investing cash flow$0-$261,617
Financing cash flow$10.67M$15.57M
Depreciation & amortization$1.04M$1.18M
Stock-based compensation$768,623$1.01M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.